1. Home
  2. LGN vs VCEL Comparison

LGN vs VCEL Comparison

Compare LGN & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LGN

Legence Corp.

N/A

Current Price

$48.45

Market Cap

2.4B

Sector

N/A

ML Signal

N/A

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$39.27

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGN
VCEL
Founded
1963
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2025
1997

Fundamental Metrics

Financial Performance
Metric
LGN
VCEL
Price
$48.45
$39.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
5
Target Price
$43.43
$57.50
AVG Volume (30 Days)
1.1M
520.7K
Earning Date
11-14-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
236.54
EPS
N/A
0.25
Revenue
$2,361,064,000.00
$258,716,999.00
Revenue This Year
$17.08
$17.86
Revenue Next Year
$32.52
$18.55
P/E Ratio
N/A
$158.71
Revenue Growth
46.19
14.05
52 Week Low
$26.96
$29.24
52 Week High
$50.20
$63.00

Technical Indicators

Market Signals
Indicator
LGN
VCEL
Relative Strength Index (RSI) N/A 55.83
Support Level N/A $35.85
Resistance Level N/A $39.07
Average True Range (ATR) 0.00 1.86
MACD 0.00 0.04
Stochastic Oscillator 0.00 61.79

Price Performance

Historical Comparison
LGN
VCEL

About LGN Legence Corp.

Legence Corp is a provider of engineering, installation and maintenance services for mission-critical systems in buildings. It focuses on high-growth sectors that have technically demanding buildings, including technology, life sciences, healthcare and education. The company specializes in designing, fabricating and installing complex HVAC, process piping and other mechanical, electrical and plumbing (MEP) systems for new facilities and upgrading HVAC, lighting and building controls in existing facilities to make them more energy efficient and sustainable.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: